Monday, November 3, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Victory Capital Gains Momentum with Record Assets and Analyst Confidence

Felix Baarz by Felix Baarz
September 14, 2025
in Analysis, Earnings, Value & Growth
0
Victory Capital Stock
0
SHARES
82
VIEWS
Share on FacebookShare on Twitter

While numerous financial sector stocks continue grappling with market volatility, Victory Capital Holdings Inc. is demonstrating a quiet but notable resilience. The US-based asset management firm is currently benefiting from a dual tailwind of expanding client assets and a recent wave of positive analyst commentary—a combination that stands out in today’s challenging equity environment.

Strategic Acquisition Fuels Record Assets

A key catalyst behind this positive momentum is the sustained growth in the firm’s assets under management (AUM). Victory Capital reported a new all-time high of $306.4 billion in client assets at the end of August. This figure represents a monthly increase of 1.3%, providing a clear indication that the company’s expansion continues unabated following its significant acquisition from Amundi.

This robust performance in asset growth has not gone unnoticed by market experts. Multiple research firms have recently revised their outlooks upward. Morgan Stanley modestly raised its price target to $67, while B. Riley Financial maintained a notably more bullish stance. The firm reaffirmed its “Buy” rating with a price target of $82.

Smooth Integration and Market Recognition

The strong numbers are underpinned by what appears to be a successful strategic integration. The acquisition of Amundi’s Pioneer Investments, finalized in April, and the subsequent merger process are progressing smoothly. This transatlantic partnership has not only contributed significant additional volume but also includes 15-year global distribution agreements, establishing a foundation for long-term growth.

Should investors sell immediately? Or is it worth buying Victory Capital?

The market is responding positively to these developments. Analysis from MarketsMojo recently upgraded Victory Capital from “very attractive” to “fairly valued,” specifically highlighting strong profitability metrics including a return on equity exceeding 25%.

Sustainability and Future Outlook

Investor attention now turns to November, when third-quarter earnings are scheduled for release. Expectations are set high with an anticipated EPS of $1.51. Recent share performance—despite a minor pullback on Friday, the stock remains positive year-to-date—suggests continued investor confidence in the company’s trajectory.

The central question moving forward is whether Victory Capital can sustain this growth through organic client acquisition and effective cross-selling initiatives across its newly expanded platforms. Should the company succeed in these efforts, the current upward trend may represent only the beginning of its growth story.

Ad

Victory Capital Stock: Buy or Sell?! New Victory Capital Analysis from November 3 delivers the answer:

The latest Victory Capital figures speak for themselves: Urgent action needed for Victory Capital investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 3.

Victory Capital: Buy or sell? Read more here...

Tags: Victory Capital
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Eli Lilly Stock
Earnings

Eli Lilly’s Meteoric Rise Fueled by Blockbuster Drugs

November 3, 2025
Liquidia Stock
Analysis

Critical Day for Liquidia as Q3 Results Approach

November 3, 2025
iShares MSCI Germany ETF Stock
Analysis

German Market ETF Faces Critical Juncture

November 3, 2025
Next Post
PrimeEnergy Stock

PrimeEnergy Shares Tumble as Crude Oil Collapse Erodes Profits

Semler Scientific Stock

Investor Lawsuits Mount Against Semler Scientific Over Undisclosed DOJ Probe

Xencor Stock

Xencor's Clinical Milestones Set to Define Biotech Investment Case

Recommended

Oxford Lane Capital Stock

Oxford Lane Capital Executes Reverse Stock Split: Investor Implications

2 months ago
DroneShield Stock

DroneShield Shares Maintain Extraordinary Growth Trajectory

1 month ago
Mobile-handsets

Anticipation Builds for Avery Dennisons Quarterly Earnings Report

2 years ago

Vontobel Holding Ltd. Invests in California Water Service Group as Analysts Express Concerns

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Poland ETF’s Heavy Concentration Raises Investor Concerns

Is Baxter’s Stock Downturn a Buying Opportunity?

Western Union’s Digital Transformation: A Bold Leap into Blockchain

AMETEK Shares Surge on Stellar Quarterly Performance

Walmart Shares Garner Unanimous Analyst Confidence Ahead of Earnings

KION Group’s Cash Flow Outlook Soars on Reduced One-Time Costs

Trending

Eli Lilly Stock
Earnings

Eli Lilly’s Meteoric Rise Fueled by Blockbuster Drugs

by Robert Sasse
November 3, 2025
0

Eli Lilly has delivered a stunning quarterly performance that shattered market expectations, driven by two revolutionary medications...

Liquidia Stock

Critical Day for Liquidia as Q3 Results Approach

November 3, 2025
iShares MSCI Germany ETF Stock

German Market ETF Faces Critical Juncture

November 3, 2025
iShares MSCI Poland ETF Stock

Poland ETF’s Heavy Concentration Raises Investor Concerns

November 3, 2025
Baxter Stock

Is Baxter’s Stock Downturn a Buying Opportunity?

November 3, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Eli Lilly’s Meteoric Rise Fueled by Blockbuster Drugs
  • Critical Day for Liquidia as Q3 Results Approach
  • German Market ETF Faces Critical Juncture

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com